Parkview Health Logo

Clinical Trials

Advancing cancer care through innovative clinical trials and research

Clinical trials are a powerful tool to help doctors and researchers discover better ways to prevent, diagnose, and treat cancer. Patients benefit from these discoveries through access to impactful new therapies, cutting-edge technologies and surgical techniques, and treatment options that may not be widely available.

The Parkview Packnett Family Cancer Institute (PFCI) works closely with the Parkview Mirro Center to bring innovative clinical trials and cancer research to our patients. This work includes studies focused on new treatments, surgical technologies and techniques, and investigational medications and devices, all with the goal of improving care and outcomes.

If you are a PFCI patient, your case will be reviewed by the Tumor Board—a multidisciplinary group of specialists who come together to discuss each patient’s diagnosis and treatment options—and it’s here that the team will also consider whether a clinical trial may be a good fit for you. Talk with your care team if you’d like to learn more or have questions.

Groundbreaking technology in neuropathy prevention

PFCI is the first cancer institute in Indiana, and one of only 15 in the United States, to offer access to a novel device called Lilac through our clinical trial. Patients undergoing cancer treatment at PFCI will be offered early access to this portable compression technology designed to help prevent chemotherapy-induced neuropathy, a damaging side effect that can cause pain, numbness, tingling, and loss of feeling in the hands and feet.
Nurse helping patient put on orthopedic boot
Genetically guided medicine

Parkview’s Precision Health Program empowers your oncologist to tailor care based on your genetic makeup.

Explore Precision Health
Orange Curve Green Curve